Insurers will not cover obesity drugs that will cost users €2,500-plus a year
Patients looking to access Eli Lilly’s Mounjaro from next week will have to pay privately
obesity
stories related to people with obesity
Human psychology: ‘Even being told you are old could affect things like blood pressure’
Research Lives: Dr Deirdre Robertson is a senior researcher at the behavioural research unit, ESRI
‘It’s kind of become our daughter’s cheat meal’: The view on new hot school meals programme
The scheme now covers nearly 2,200 schools, and 345,000 children, but some parents and teachers have concerns about nutritional standards
Novo Nordisk shares tumble as weight-loss drug trial data disappoints
Obesity drug CagriSema misses goal of 25% body weight reduction
It’s time for a reality check about certain ‘weight loss’ drugs, and here’s why
Much hype surrounds drugs called GLP-1 agonists but they are intended for diabetes patients and people who are obese, not those who just want to lose a few pounds
Chief obesity clinician Prof Donal O’Shea ‘shocked’ at prevalence of black market ‘skinny jabs’
RTÉ Investigates programme to be aired on Monday examines illegitimate sales of weight loss drugs, despite some being labelled as ‘not for human use’
Lilly’s Zepbound tops Novo Nordisk’s Wegovy for weight loss in head-to-head trial
Companies competing for leadership in fast-growing market where supply continues to be an issue
Prof Donal O’ Shea: ‘The positioning of Ronald McDonald House at the entrance to the new children’s hospital makes me angry’
Prof Donal O’ Shea is the HSE lead on obesity and a regular commentator on the dangers of marketing ‘junk and fast food’ to children
Robert Kennedy jnr: Pharma investors brace for impact
Vaccine makers and companies manufacturing breakthrough obesity drugs saw share prices fall on nomination
Covid factor chills profits at pharma group West
US packaging giant backing huge demand for injectable obesity drugs to fill the gap left by falling demand for Covid vaccines
Pharma packaging group West announces 330 jobs for Dublin
Announcement is first major investment by a US multinational following Trump victory in presidential election
Britain’s anti-obesity jab plan is the stuff of sci-fi
Drastic action is considered essential, but this is part of a wider strategy that represents a looming calamity for Stormont
Goodbye BMI, hello BRI: Is roundness a better measure of health than mass?
BMI is criticised for treating fat and muscle mass the same. Does a newer measure solve the problem?
Lilly turns to Ireland to produce two of the hottest therapy areas in medicine
Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy
As a cardiologist, here is what I tell my patients about Ozempic
Using such medications to lose excess fat that risks your health is no more of a moral failing than using a blood pressure medication to lower high blood pressure that increases your risk of stroke
‘I see my belly, and my belly sees me. Yes, my diet has really gone belly up’
Enda Sheppard: I resemble more and more a front-loading camel, stocking up for the long winter ahead. Except it’s nowhere near winter
Plain packaging worked to reduce smoking. Unhealthy food should be next
Removing branding from cigarette boxes has reduced smoking among young people. We must now do the same with unhealthy food and drinks as childhood obesity can trigger disease in later life
Weight loss drug semaglutide could reduce heart attack risk by 20%, study finds
Active ingredient in brands including Wegovy and Ozempic also found to have brought about cardiovascular benefits for participants in research
Hot school meals: A close look at the ingredients list is not pretty. This is industrial food
While aimed at child health and rolled out impressively fast, school food merits better use of public money by the Government
Ozempic changed the lives of obesity patients. And then we had to stop prescribing it
Patients are being denied access to a potentially life-saving obesity treatment
Is corporate PR duping us and derailing solutions to global warming and chronic diseases?
‘We need to go back to basics to organise ourselves in groups, to have clear political objectives and to demand change’
Living with obesity: ‘You would lose three stone in two weeks, but then in four weeks you would put 3½ back on’
Having felt a sense of shame and failure for years, bariatric surgery proved life-changing for electrical contractor Joe Meade
‘Tide is turning more rapidly than ever in terms of obesity management’
Disadvantaged groups, however, continue to be disproportionately affected by an overall rise obesity over the past 30-plus years
Ozempic has big potential, but caution is necessary
For all the popular clamour for the new medication it is not without side effects
Man’s death after weight-loss surgery in Turkey leaves family with unanswered questions
‘He wouldn’t want to die, nobody wants to,’ says wife of Cristian Nascimento (26) who died in Cavan 21 days after returning from Istanbul clinic
Healthy plant-based diet can eliminate many type 2 diabetes cases, study finds
Diet high in fruit, vegetables and wholegrains can reduce risk by 24%, even for those with added risk factors
Pfizer outlook gloomy after annus horribilis in 2023
Pharmaceutical giant suffers a post-Covid-19 hangover as demand for pandemic vaccines and medicines falls sharply
Ozempic maker Novo Nordisk buys Irish drug manufacturing plant in €85m deal
Danish weight loss and diabetes specialist is looking to develop a tablet form of its blockbuster obesity treatments
Demand for weight loss drug more than 45 times higher than expected
New obesity medicines have potential to use up entire State drugs budget, conference hears
The Truth About the ‘Skinny’ Jab: Are weight-loss injections a magic wand or potential health disaster?
Television: Presenter Anna Richardson explores how drugs like Ozempic and Wegovy work and the potential side effects
Call for creation of register logging patients having weight-loss surgery abroad
Medics detail complications experienced by four patients who travelled for surgeries in article
Novo Nordisk says obesity pill leads to 15% weight loss
Danish drugmaker pushing for US and EU approval but has struggled to meet demand for its Ozempic and Wegovy drugs
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Six Nations 2025
Get the latest news, analysis and match reports from the M6N and W6N championships
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices